A phase II trial of recombinant human granulocyte colony-stimulating factor in the myelodysplastic syndromes
- 1 July 1991
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 78 (3), 378-384
- https://doi.org/10.1111/j.1365-2141.1991.tb04451.x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Hematologic and Cytogenetic Findings in Myelodysplastic Syndromes Treated with Recombinant Human Granulocyte Colony‐stimulating FactorJapanese Journal of Cancer Research, 1989
- HAEMOPOIETIC GROWTH FACTORS 2: CLINICAL APPLICATIONSThe Lancet, 1989
- Effects of purified human native granulocyte colony-stimulating factor (G-CSF) on proliferation of blast progenitors in acute myeloblastic leukemiaAmerican Journal of Hematology, 1988
- Effects of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor in Patients with Myelodysplastic SyndromesNew England Journal of Medicine, 1987
- Granulocyte colony‐stimulating factor and differentiation‐induction in myeloid leukemic cellsThe International Journal of Cell Cloning, 1987
- Biology of myelodysplastic syndromesThe International Journal of Cell Cloning, 1987
- Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factorNature, 1986
- Myelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implications.Journal of Clinical Pathology, 1985
- Purified Human Granulocyte-Macrophage Colony-Stimulating Factor: Direct Action on NeutrophilsScience, 1984
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982